Cargando…

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke

Cerebrovascular accidents (CVA) or strokes cause focal neurological deficits, which may be due to rupture or occlusion of blood vessels supplying areas of the brain. Atrial fibrillation (AF) is an independent and significant risk factor for ischemic CVA, mainly via the embolic pathway. This is evide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amoda, Oluyemisi, A, Elmarie, Uwagbale, Ese
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310612/ https://www.ncbi.nlm.nih.gov/pubmed/34322355 http://dx.doi.org/10.7759/cureus.15915

Ejemplares similares

Chronic Eosinophilic Pneumonia Masquerading as a Lung Mass
por: Amoda, Oluyemisi, et al.
Publicado: (2022)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

Single-Center Outcomes of WATCHMAN™ Implantation with Comparison to Oral Anticoagulant and Dual Antiplatelet Therapy
por: Demiraj, Francis, et al.
Publicado: (2023)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021)

Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Anticoagulation After Ischemic Stroke or Transient Ischemic Attack (TIA) in the Time of Direct Oral Anticoagulation (DOAC) and Thrombectomy
por: Martin Diaz, Claudia, et al.
Publicado: (2021)

Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
por: Khazaal, Ossama, et al.
Publicado: (2021)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis
por: Xu, Zhaohan, et al.
Publicado: (2022)

Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Predicting Chronic Subdural Hematoma Recurrence and Stroke Outcomes While Withholding Antiplatelet and Anticoagulant Agents
por: Zanaty, Mario, et al.
Publicado: (2020)

Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry
por: Gutiérrez-Zúñiga, Raquel, et al.
Publicado: (2020)

Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke
por: Xian, Ying, et al.
Publicado: (2022)

Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome
por: Okuma, Hirohisa, et al.
Publicado: (2009)

Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
por: Kang, Hyun Goo, et al.
Publicado: (2021)

Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
por: Anjum, Ibrar, et al.
Publicado: (2018)

No Time to Lose: Cases of Anticoagulant Reversal Before Thrombolysis in Acute Ischemic Stroke Patients
por: Amin, Sheyar, et al.
Publicado: (2022)

Management of Oral Anticoagulation and Antiplatelet Therapy in Post-Myocardial Infarction Patients with Acute Ischemic Stroke with and without Atrial Fibrillation
por: Pezzella, Francesca Romana, et al.
Publicado: (2022)

A Case of Stercoral Colitis Complicated by Ischemic Colitis in a Young Patient
por: Uwagbale, Ese, et al.
Publicado: (2022)

Efficacy and Safety of Anticoagulant Therapy Versus Antiplatelet Therapy in Acute Ischemic Stroke Patients with Atrial Fibrillation
por: Yan, Xiaodi, et al.
Publicado: (2023)

Acute Secondary Prevention of Ischemic Stroke: Overlooked No Longer
por: Bulwa, Zachary B., et al.
Publicado: (2021)

Failure of Therapeutic Anticoagulation in COVID-19 Patients With Acute Ischemic Stroke. A Retrospective Multicenter Study
por: Janes, Francesco, et al.
Publicado: (2022)

Anti-inflammatory and antiplatelet effects of non-vitamin K antagonist oral anticoagulants in acute phase of ischemic stroke patients
por: Nakase, Taizen, et al.
Publicado: (2018)

Comparing the Effectiveness of Intravenous Tissue Plasminogen Activator and Dual Antiplatelet Therapy in Patients With Minor Stroke: A Meta-Analysis
por: Monday, Obinna, et al.
Publicado: (2023)

Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation—A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation
por: Rose, David Z., et al.
Publicado: (2019)

Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke
por: He, Dan, et al.
Publicado: (2022)

Pacemaker lead malpositioning led to subsequent ischemic strokes despite antiplatelet and anticoagulation therapy
por: Rath, Claus, et al.
Publicado: (2014)

Decision-Making Process for the Management of Acute Stroke in Patients on Oral Anticoagulant: From Guidelines to Clinical Routine
por: Sibon, Igor, et al.
Publicado: (2022)

Editorial: Reperfusion Therapy for Acute Ischemic Stroke
por: Mishra, Nishant K., et al.
Publicado: (2019)

Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry
por: Wagner, Benjamin, et al.
Publicado: (2022)

Appropriate use of antiplatelet medications following transient ischemic attacks and stroke: a 9-year study from the Middle East
por: Naveed, Hiba, et al.
Publicado: (2023)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
por: Choi, Kang-Ho, et al.
Publicado: (2021)

Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons
por: Hong, Keun-Sik
Publicado: (2014)

Impact of Non-vitamin K Antagonist Oral Anticoagulant Withdrawal on Stroke Outcomes
por: Park, Joong Hyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uiaud9u83icq3mkncv7rf4f8eu